Global Polio Vaccine Market Analysis and Forecast 2024-2030

Global Polio Vaccine Market Analysis and Forecast 2024-2030


Summary

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.

According to APO Research, The global Polio Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Polio Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Polio Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Polio Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Polio Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Polio Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Polio Vaccine sales, projected growth trends, production technology, application and end-user industry.

Polio Vaccine segment by Company

Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Polio Vaccine segment by Type

Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Polio Vaccine segment by Application

Public
Private
Polio Vaccine segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Polio Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Polio Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Polio Vaccine Market by Type
1.2.1 Global Polio Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Polio Vaccine Market by Application
1.3.1 Global Polio Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Public
1.3.3 Private
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Polio Vaccine Market Dynamics
2.1 Polio Vaccine Industry Trends
2.2 Polio Vaccine Industry Drivers
2.3 Polio Vaccine Industry Opportunities and Challenges
2.4 Polio Vaccine Industry Restraints
3 Global Market Growth Prospects
3.1 Global Polio Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Polio Vaccine Revenue by Region
3.2.1 Global Polio Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Polio Vaccine Revenue by Region (2019-2024)
3.2.3 Global Polio Vaccine Revenue by Region (2025-2030)
3.2.4 Global Polio Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Polio Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Polio Vaccine Sales by Region
3.4.1 Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Polio Vaccine Sales by Region (2019-2024)
3.4.3 Global Polio Vaccine Sales by Region (2025-2030)
3.4.4 Global Polio Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Polio Vaccine Revenue by Manufacturers
4.1.1 Global Polio Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Polio Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Polio Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Polio Vaccine Sales by Manufacturers
4.2.1 Global Polio Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Polio Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Polio Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Polio Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Polio Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Polio Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Polio Vaccine Manufacturers, Product Type & Application
4.7 Global Polio Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Polio Vaccine Market CR5 and HHI
4.8.2 2023 Polio Vaccine Tier 1, Tier 2, and Tier 3
5 Polio Vaccine Market by Type
5.1 Global Polio Vaccine Revenue by Type
5.1.1 Global Polio Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Polio Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Polio Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Polio Vaccine Sales by Type
5.2.1 Global Polio Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Polio Vaccine Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Polio Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Polio Vaccine Price by Type
6 Polio Vaccine Market by Application
6.1 Global Polio Vaccine Revenue by Application
6.1.1 Global Polio Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Polio Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Polio Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Polio Vaccine Sales by Application
6.2.1 Global Polio Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Polio Vaccine Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Polio Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Polio Vaccine Price by Application
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Comapny Information
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Sanofi Polio Vaccine Product Portfolio
7.1.5 Sanofi Recent Developments
7.2 GSK
7.2.1 GSK Comapny Information
7.2.2 GSK Business Overview
7.2.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 GSK Polio Vaccine Product Portfolio
7.2.5 GSK Recent Developments
7.3 Bibcol
7.3.1 Bibcol Comapny Information
7.3.2 Bibcol Business Overview
7.3.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Bibcol Polio Vaccine Product Portfolio
7.3.5 Bibcol Recent Developments
7.4 Serum Institute
7.4.1 Serum Institute Comapny Information
7.4.2 Serum Institute Business Overview
7.4.3 Serum Institute Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Serum Institute Polio Vaccine Product Portfolio
7.4.5 Serum Institute Recent Developments
7.5 Tiantan Biological
7.5.1 Tiantan Biological Comapny Information
7.5.2 Tiantan Biological Business Overview
7.5.3 Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Tiantan Biological Polio Vaccine Product Portfolio
7.5.5 Tiantan Biological Recent Developments
7.6 IMBCA
7.6.1 IMBCA Comapny Information
7.6.2 IMBCA Business Overview
7.6.3 IMBCA Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 IMBCA Polio Vaccine Product Portfolio
7.6.5 IMBCA Recent Developments
7.7 Panacea Biotec Ltd
7.7.1 Panacea Biotec Ltd Comapny Information
7.7.2 Panacea Biotec Ltd Business Overview
7.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
7.7.5 Panacea Biotec Ltd Recent Developments
7.8 Bio-Med
7.8.1 Bio-Med Comapny Information
7.8.2 Bio-Med Business Overview
7.8.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Bio-Med Polio Vaccine Product Portfolio
7.8.5 Bio-Med Recent Developments
7.9 Halfkin Bio-Pharmaceuticals
7.9.1 Halfkin Bio-Pharmaceuticals Comapny Information
7.9.2 Halfkin Bio-Pharmaceuticals Business Overview
7.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
7.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
8 North America
8.1 North America Polio Vaccine Market Size by Type
8.1.1 North America Polio Vaccine Revenue by Type (2019-2030)
8.1.2 North America Polio Vaccine Sales by Type (2019-2030)
8.1.3 North America Polio Vaccine Price by Type (2019-2030)
8.2 North America Polio Vaccine Market Size by Application
8.2.1 North America Polio Vaccine Revenue by Application (2019-2030)
8.2.2 North America Polio Vaccine Sales by Application (2019-2030)
8.2.3 North America Polio Vaccine Price by Application (2019-2030)
8.3 North America Polio Vaccine Market Size by Country
8.3.1 North America Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Polio Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Polio Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Polio Vaccine Market Size by Type
9.1.1 Europe Polio Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Polio Vaccine Sales by Type (2019-2030)
9.1.3 Europe Polio Vaccine Price by Type (2019-2030)
9.2 Europe Polio Vaccine Market Size by Application
9.2.1 Europe Polio Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Polio Vaccine Sales by Application (2019-2030)
9.2.3 Europe Polio Vaccine Price by Application (2019-2030)
9.3 Europe Polio Vaccine Market Size by Country
9.3.1 Europe Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Polio Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Polio Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Polio Vaccine Market Size by Type
10.1.1 China Polio Vaccine Revenue by Type (2019-2030)
10.1.2 China Polio Vaccine Sales by Type (2019-2030)
10.1.3 China Polio Vaccine Price by Type (2019-2030)
10.2 China Polio Vaccine Market Size by Application
10.2.1 China Polio Vaccine Revenue by Application (2019-2030)
10.2.2 China Polio Vaccine Sales by Application (2019-2030)
10.2.3 China Polio Vaccine Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Polio Vaccine Market Size by Type
11.1.1 Asia Polio Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Polio Vaccine Sales by Type (2019-2030)
11.1.3 Asia Polio Vaccine Price by Type (2019-2030)
11.2 Asia Polio Vaccine Market Size by Application
11.2.1 Asia Polio Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Polio Vaccine Sales by Application (2019-2030)
11.2.3 Asia Polio Vaccine Price by Application (2019-2030)
11.3 Asia Polio Vaccine Market Size by Country
11.3.1 Asia Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Polio Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Polio Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Polio Vaccine Market Size by Type
12.1.1 MEALA Polio Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Polio Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Polio Vaccine Price by Type (2019-2030)
12.2 MEALA Polio Vaccine Market Size by Application
12.2.1 MEALA Polio Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Polio Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Polio Vaccine Price by Application (2019-2030)
12.3 MEALA Polio Vaccine Market Size by Country
12.3.1 MEALA Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Polio Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Polio Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Polio Vaccine Value Chain Analysis
13.1.1 Polio Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Polio Vaccine Production Mode & Process
13.2 Polio Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Polio Vaccine Distributors
13.2.3 Polio Vaccine Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings